Two Sigma Investments’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.5K | Buy |
+32,682
| New | +$75.5K | ﹤0.01% | 2981 |
|
|
2025
Q1 | – | Sell |
-12,300
| Closed | -$21.3K | – | 3431 |
|
|
2024
Q4 | $21.3K | Buy |
+12,300
| New | +$21.3K | ﹤0.01% | 3036 |
|
|
2024
Q2 | – | Sell |
-121,517
| Closed | -$349K | – | 3250 |
|
|
2024
Q1 | $349K | Sell |
121,517
-15,456
| -11% | -$44.4K | ﹤0.01% | 2426 |
|
|
2023
Q4 | $242K | Buy |
+136,973
| New | +$242K | ﹤0.01% | 2684 |
|
|
2022
Q4 | – | Sell |
-43,378
| Closed | -$84K | – | 3032 |
|
|
2022
Q3 | $84K | Sell |
43,378
-24,266
| -36% | -$47K | ﹤0.01% | 2204 |
|
|
2022
Q2 | $252K | Sell |
67,644
-114,264
| -63% | -$426K | ﹤0.01% | 2020 |
|
|
2022
Q1 | $1.19M | Buy |
181,908
+112,679
| +163% | +$735K | ﹤0.01% | 1600 |
|
|
2021
Q4 | $807K | Buy |
+69,229
| New | +$807K | ﹤0.01% | 1754 |
|